Thesan Pharmaceuticals

Preclinical biopharmaceutical company developing novel therapeutics for skin disorders.

Launch date

2011

Employees

Market cap

Enterprise valuation

San Clemente California (HQ)

Date	Investors	Amount	Round
-	Lundbeckfonden	N/A	-
Oct 2012	Novo Ventures Novartis Venture Fund	$16.0m	Series A
Feb 2014	Novo Ventures Lundbeckfonden Ventures Johnson & Johnson Ipsen SV Health Investors Novartis Venture Fund	$49.0m	Series B
Jan 2016	SV Health Investors	N/A	Series B
Total Funding		CAD88.6m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Thesan Pharmaceuticals